TY - JOUR
T1 - Milk and Dairy Products Intake Is Related to Cognitive Impairment at Baseline in Predimed Plus Trial
AU - PREDIMED-PLUS investigators
AU - Muñoz-Garach, Araceli
AU - Cornejo-Pareja, Isabel
AU - Martínez-González, Miguel Ángel
AU - Bulló, Monica
AU - Corella, Dolores
AU - Castañer, Olga
AU - Romaguera, Dora
AU - Vioque, Jesús
AU - Alonso-Gómez, Ángel M.
AU - Wärnberg, Julia
AU - Martínez, J. Alfredo
AU - Serra-Majem, Luís
AU - Estruch, Ramon
AU - Bernal-López, M. Rosa
AU - Lapetra, José
AU - Pintó, Xavier
AU - Tur, Josep A.
AU - López-Miranda, José
AU - Bueno-Cavanillas, Aurora
AU - Delgado-Rodríguez, Miguel
AU - Matía-Martín, Pilar
AU - Daimiel, Lidia
AU - Sánchez, Vicente Martín
AU - Vidal, Josep
AU - Prieto, Lucia
AU - Ros, Emilio
AU - Fernández-Aranda, Fernando
AU - Camacho-Barcia, Lucía
AU - Ortega-Azorin, Carolina
AU - Soria, María
AU - Fiol, Miquel
AU - Compañ-Gabucio, Laura
AU - Goicolea-Güemez, Leire
AU - Pérez-López, Jessica
AU - Goñi, Nuria
AU - Pérez-Cabrera, Judith
AU - Sacanella, E.
AU - Fernández-García, Jose Carlos
AU - Miró-Moriano, Leticia
AU - Gimenez-Gracia, M.
AU - Razquin, C.
AU - Paz-Graniel, Indira
AU - Guillem, Patricia
AU - Zomeño, María Dolors
AU - Moñino, Manuel
AU - Oncina-Canovas, Alejandro
AU - Salaverria-Lete, Itziar
AU - Toledo, Estefanía
AU - Salas-Salvadó, Jordi
AU - Schröder, Helmut
N1 - Funding Information:
The authors acknowledge M. Repice for English language editing of this article. This work was supported in part by grants from Instituto de Salud Carlos III (PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, and PI17/00926); the Cohorte PREDIMED-PLUS grant; the European Research Council (Advanced Research Grant 2013–2018, 340918); the Recercaixa grant (2013ACUP00194); grants from Consejeria de Salud de la Junta de Andalucia (PI0458/2013, PS0358/2016, PI0092/2017, PI0096/2017 and PI0137/2018); a grant from the Generalitat Valenciana (PROMETEO/2017/017); a SEMERGEN grant, and funds from the European Regional Development Fund (CB06/03). This study has been co-funded by FEDER funds. A.M-G. is the recipient of a postdoctoral grant (Juan Rodes JR 17/00023) from the Spanish Ministry of Economy and Competitiveness. I.C.-P. was supported by Rio Hortega (CM17/00169) and now is the recipient of a postdoctoral grant (Juan Rodes JR19/00054) from the Spanish Ministry of Economy and Competitiveness. J.C.F.-G. was supported by a research contract from the Servicio Andaluz de Salud (SAS) (B-0003-2017). I.P.G. has received a grant from the Spanish Ministry of Education, Culture and Sports (FPU 17/01925). M.R.B.-L. was supported by “Miguel Servet Type I” program (CP15/00028) from the ISCIII-Madrid (Spain), cofinanced by the Fondo Europeo de Desarrollo Regional-FEDER.
Funding Information:
The authors acknowledge M. Repice for English language editing of this article. This work was supported in part by grants from Instituto de Salud Carlos III (PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, and PI17/00926); the Cohorte PREDIMED‐PLUS grant; the European Research Council (Advanced Research Grant 2013–2018, 340918); the Recercaixa grant (2013ACUP00194); grants from Consejeria de Salud de la Junta de Andalucia (PI0458/2013, PS0358/2016, PI0092/2017, PI0096/2017 and PI0137/2018); a grant from the Generalitat Valenciana (PROMETEO/2017/017); a SEMERGEN grant, and funds from the European Regional Development Fund (CB06/03). This study has been co‐funded by FEDER funds. A.M‐G. is the recipient of a postdoctoral grant (Juan Rodes JR 17/00023) from the Spanish Ministry of Economy and Competitiveness. I.C.‐P. was supported by Rio Hortega (CM17/00169) and now is the recipient of a postdoctoral grant (Juan Rodes JR19/00054) from the Spanish Ministry of Economy and Competitiveness. J.C.F.‐G. was supported by a research contract from the Servicio Andaluz de Salud (SAS) (B‐0003‐2017). I.P.G. has received a grant from the Spanish Ministry of Education, Culture and Sports (FPU 17/01925). M.R.B.‐L. was supported by “Miguel Servet Type I” program (CP15/00028) from the ISCIII‐Madrid (Spain), cofinanced by the Fondo Europeo de Desarrollo Regional‐FEDER.
Publisher Copyright:
© 2021 Wiley-VCH GmbH
PY - 2021/4
Y1 - 2021/4
N2 - Scope: To examine the association between milk and dairy products intake and the prevalence of cognitive decline among Spanish individuals at high cardiovascular risk. Methods and results: Cross-sectional analyses are performed on baseline data from 6744 adults (aged 55–75 years old). Intake of milk and dairy products is estimated using a food frequency questionnaire grouped into quartiles. The risk of developing cognitive impairment is based on the Mini-Mental State Examination (MMSE). A higher prevalence of cognitive decline was found in subjects who consumed more grams. Patients with worse MMSE score (10–24) consumed a mean of 395.14 ± 12.21 g, while patients with better MMSE score (27–30) consumed a mean of 341.23 ± 2.73 g (p < 0.05). Those subjects with the lower milk consumption (<220 g/day) had a higher MMSE score (28.35 ± 0.045). Higher intake of fermented dairy products was observed in participants with a lower MMSE score (OR 1.340, p = 0.003). A positive correlation was found between the consumption of whole milk and the MMSE score (r = 0.066, p < 0.001). Conclusions: These findings suggest that greater consumption of milk and dairy products could be associated with greater cognitive decline according to MMSE. Conversely, consumption of whole-fat milk could be linked with less cognitive impairment in the cross-sectional study.
AB - Scope: To examine the association between milk and dairy products intake and the prevalence of cognitive decline among Spanish individuals at high cardiovascular risk. Methods and results: Cross-sectional analyses are performed on baseline data from 6744 adults (aged 55–75 years old). Intake of milk and dairy products is estimated using a food frequency questionnaire grouped into quartiles. The risk of developing cognitive impairment is based on the Mini-Mental State Examination (MMSE). A higher prevalence of cognitive decline was found in subjects who consumed more grams. Patients with worse MMSE score (10–24) consumed a mean of 395.14 ± 12.21 g, while patients with better MMSE score (27–30) consumed a mean of 341.23 ± 2.73 g (p < 0.05). Those subjects with the lower milk consumption (<220 g/day) had a higher MMSE score (28.35 ± 0.045). Higher intake of fermented dairy products was observed in participants with a lower MMSE score (OR 1.340, p = 0.003). A positive correlation was found between the consumption of whole milk and the MMSE score (r = 0.066, p < 0.001). Conclusions: These findings suggest that greater consumption of milk and dairy products could be associated with greater cognitive decline according to MMSE. Conversely, consumption of whole-fat milk could be linked with less cognitive impairment in the cross-sectional study.
KW - cognition
KW - cognitive decline
KW - consumption
KW - dairy products
KW - milk
UR - http://www.scopus.com/inward/record.url?scp=85114327615&partnerID=8YFLogxK
U2 - 10.1002/mnfr.202000728
DO - 10.1002/mnfr.202000728
M3 - Article
AN - SCOPUS:85114327615
SN - 1613-4125
VL - 65
JO - Molecular Nutrition and Food Research
JF - Molecular Nutrition and Food Research
IS - 7
M1 - 2000728
ER -